Abstract:Background Fluorescence molecular imaging using ABY-029, an epidermal growth factor receptor (EGFR)-targeted, synthetic Affibody peptide labeled with a near-infrared fluorophore, is under investigation for surgical guidance during head and neck squamous cell carcinoma (HNSCC) resection. However, tumor-to-normal tissue contrast is confounded by intrinsic physiological limitations of heterogeneous EGFR expression and non-specific agent uptake. Objective In this preliminary study, radiomic analysis was applied to optical ABY-029 fluorescence image data for HNSCC tissue classification through an approach termed “optomics.” Optomics was employed to improve tumor identification by leveraging textural pattern differences in EGFR expression conveyed by fluorescence. The study objective was to compare the performance of conventional fluorescence intensity thresholding and optomics for binary classification of malignant vs. non-malignant HNSCC tissues. Materials and Methods Fluorescence image data collected through a Phase 0 clinical trial of ABY-029 involved a total of 20,073 sub-image patches (size of 1.8 × 1.8 mm 2 ) extracted from 24 bread-loafed slices of HNSCC surgical resections originating from 12 patients who were stratified into three dose groups (30, 90, and 171 nanomoles). Each dose group was randomly partitioned on the specimen-level 75%/25% into training/testing sets, then all training and testing sets were aggregated. A total of 1,472 standardized radiomic features were extracted from each patch and evaluated by minimum redundancy maximum relevance feature selection, and 25 top-ranked features were used to train a support vector machine (SVM) classifier. Predictive performance of the SVM classifier was compared to fluorescence intensity thresholding for classifying testing set image patches with histologically confirmed malignancy status. Results Optomics provided consistent improvement in prediction accuracy and false positive rate (FPR) and similar false negative rate (FNR) on all testing set slices, irrespective of dose, compared to fluorescence intensity thresholding (mean accuracies of 89% vs. 81%, P = 0.0072; mean FPRs of 12% vs. 21%, P = 0.0035; and mean FNRs of 13% vs. 17%, P = 0.35). Conclusions Optomics outperformed conventional fluorescence intensity thresholding for tumor identification using sub-image patches as the unit of analysis. Optomics mitigate diagnostic uncertainties introduced through physiological variability, imaging agent dose, and inter-specimen biases of fluorescence molecular imaging by probing textural image information. This preliminary study provides a proof-of-concept that applying radiomics to fluorescence molecular imaging data offers a promising image analysis technique for cancer detection in fluorescence-guided surgery.

Key native fluorophores analysis of human breast cancer tissues using Gram-Schmidt subspace method.

Classification of autofluorescence spectra using the algorithm based on support vector machine

Classification of in Vivo Autofluorescence Spectra Using Support Vector Machines

Native fluorescence spectra of human cancerous and normal breast tissues analyzed with non-negative constraint methods

Combined Classifier for Discriminating Cancerous Tissue from Normal Tissue Using Light-Induced Autofluorescence

Study of Serum Fluorescence and Raman Spectra for Diagnosis of Cancer

A Spectral Dissimilarity Constrained Nonnegative Matrix Factorization Based Cancer Screening Algorithm from Hyperspectral Fluorescence Images.

Diagnosis of Breast Cancer Tissues Using 785 Nm Miniature Raman Spectrometer and Pattern Regression.

Studies on Human Breast Cancer Tissues with Raman Microspectroscopy

Correlation coefficient mapping in fluorescence spectroscopy: tissue classification for cancer detection

Resonance Raman spectroscopy for human cancer detection of key molecules with clinical diagnosis

Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy

Machine learning approaches in non-contact autofluorescence spectrum classification

Development of an Endoscopic Auto-Fluorescent Sensing Device to Aid in the Detection of Breast Cancer and Inform Photodynamic Therapy

Visible and near-infrared spectroscopy for distinguishing malignant tumor tissue from benign tumor and normal breast tissues in vitro

Label-free Biomolecular Characterization of Human Breast Cancer Tissue with Stimulated Raman Scattering (SRS) Spectral Imaging (conference Presentation)

Diagnosis of human breast cancer through wavelet transform of polarized fluorescence

Low coherence quantitative phase microscopy with machine learning model and Raman spectroscopy for the study of breast cancer cells and their classification

Monte Carlo Modeling of Near-infrared Fluorescence Photon Migration in Breast Tissue for Tumor Prediction

Fluorescence molecular optomic signatures improve identification of tumors in head and neck specimens

Cancer diagnostics using fluorescence/reflectance spectroscopy with a fiber optic point probe and least-squares support vector machines